Data Year:

For its 2025 fiscal year, ZIMMER BIOMET HOLDINGS INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
Ivan Tornos
Chairman, President and CEO
Total Compensation $16,106,550 View details Pay Rank By Title In MFG Durable industry #91 View more
Suketu Upadhyay
CFO and EVP - Finance, Operations and Supply Chain
Total Compensation $6,211,804 View details Pay Rank By Title In MFG Durable industry #75 View more
Wilfred van Zuilen
Group President, EMEA
Total Compensation $3,585,906 View details Pay Rank By Title In MFG Durable industry #49 View more
Kevin Thornal
Group President, Global Businesses and the Americas
Total Compensation $6,210,745 View details Pay Rank By Title In MFG Durable industry #14 View more
Jehanzeb Noor
SVP, Chief Strategy, Business Development,Innovation and Transformation Officer
Total Compensation $7,657,043 View details Pay Rank By Title In MFG Durable industry #14 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at ZIMMER BIOMET HOLDINGS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. ZIMMER BIOMET HOLDINGS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. ZIMMER BIOMET HOLDINGS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Ivan Tornos
Chairman, President and CEO
Total Cash $3,702,613 Equity $12,000,101 Other $403,836 $16,106,550
Suketu Upadhyay
CFO and EVP - Finance, Operations and Supply Chain
Total Cash $2,048,416 Equity $4,000,104 Other $163,284 $6,211,804
Wilfred van Zuilen
Group President, EMEA
Total Cash $1,473,482 Equity $2,000,052 Other $112,372 $3,585,906
Kevin Thornal
Group President, Global Businesses and the Americas
Total Cash $910,660 Equity $5,300,085 Other $0 $6,210,745
Jehanzeb Noor
SVP, Chief Strategy, Business Development,Innovation and Transformation Officer
Total Cash $2,529,422 Equity $5,100,212 Other $27,409 $7,657,043
For its 2025 fiscal year, ZIMMER BIOMET HOLDINGS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Ivan Tornos CEO Pay $16,106,550 Median Employee Pay $80,380 CEO Pay Ratio 200:1
For its 2025 fiscal year, ZIMMER BIOMET HOLDINGS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Arthur J. Higgins Total Cash $348,104
Betsy J. Bernard Total Cash $349,258
Christopher B. Begley Total Cash $135,546
Devdatt Kurdikar Total Cash $370,927
Louis A. Shapiro Total Cash $371,584
Maria Teresa Hilado Total Cash $343,132
Michael J. Farrell Total Cash $370,427
Robert A. Hagemann Total Cash $356,348
Sreelakshmi Kolli Total Cash $396,966
Syed Jafry Total Cash $352,563
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.